Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.Clin Obstet Gynecol. 2007 Mar; 50(1):226-43.CO
Abstract
This review systematically addresses the evidence confirming polycystic ovary syndrome (PCOS) as a cardiovascular health threat. Literature in this area is void of long-term prospective studies to adequately evaluate outcome, but there is important evidence using surrogate markers for future development of and presence of cardiovascular disease and diabetes in women with PCOS. In addition, this article reviews the evidence regarding evaluation and management of cardiovascular risk factors in the population of women with PCOS. We seek to review the literature to determine when or if recommendations for management of women with PCOS should deviate from guidelines for the population at large.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
17304038
Clinical Trial Links
Citation
Lorenz, Landon B., and Robert A. Wild. "Polycystic Ovarian Syndrome: an Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today's Clinician." Clinical Obstetrics and Gynecology, vol. 50, no. 1, 2007, pp. 226-43.
Lorenz LB, Wild RA. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Clin Obstet Gynecol. 2007;50(1):226-43.
Lorenz, L. B., & Wild, R. A. (2007). Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Clinical Obstetrics and Gynecology, 50(1), 226-43.
Lorenz LB, Wild RA. Polycystic Ovarian Syndrome: an Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today's Clinician. Clin Obstet Gynecol. 2007;50(1):226-43. PubMed PMID: 17304038.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
AU - Lorenz,Landon B,
AU - Wild,Robert A,
PY - 2007/2/17/pubmed
PY - 2007/4/18/medline
PY - 2007/2/17/entrez
SP - 226
EP - 43
JF - Clinical obstetrics and gynecology
JO - Clin Obstet Gynecol
VL - 50
IS - 1
N2 - This review systematically addresses the evidence confirming polycystic ovary syndrome (PCOS) as a cardiovascular health threat. Literature in this area is void of long-term prospective studies to adequately evaluate outcome, but there is important evidence using surrogate markers for future development of and presence of cardiovascular disease and diabetes in women with PCOS. In addition, this article reviews the evidence regarding evaluation and management of cardiovascular risk factors in the population of women with PCOS. We seek to review the literature to determine when or if recommendations for management of women with PCOS should deviate from guidelines for the population at large.
SN - 0009-9201
UR - https://www.unboundmedicine.com/medline/citation/17304038/Polycystic_ovarian_syndrome:_an_evidence_based_approach_to_evaluation_and_management_of_diabetes_and_cardiovascular_risks_for_today's_clinician_
L2 - https://dx.doi.org/10.1097/GRF.0b013e31802f5197
DB - PRIME
DP - Unbound Medicine
ER -